IS BCG AN ORPHAN DRUG SUFFERING FROM CHEMOTHERAPISTS OVERKILL

[41] LAMM DL, 1983, P AM SOC CLIN ONCOL, V2, P55

[42] MANDEVILLE R, 1983, CANCER IMMUNOL IMMUN, V15, P17

[43] MARTINEZPINEIRO JA, 1984, EUR UROL, V10, P93

[44] ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKAEMIA [J]. LANCET, 1969, 1 (7597) : 697 - +

[45] MATTHAY RA, 1982, IMMUNOTHERAPY HUMAN, P69

[46] MCCRACKEN JD, 1982, CANCER, V49, P2252, DOI 10.1002/1097-0142(19820601)49:11<2252::AID-CNCR2820491109>3.0.CO

[47] 2-L

[48] MCCULLOCH PB, 1982, IMMUNOTHERAPY HUMAN, P183

[49] MCKNEALLY MF, 1982, IMMUNOTHERAPY HUMAN, P87

[50] MCPHERSON TA, 1984, 4TH INT C ADJ THER C, P64

[41] LAMM DL, 1983, P AM SOC CLIN ONCOL, V2, P55

[42] MANDEVILLE R, 1983, CANCER IMMUNOL IMMUN, V15, P17

[43] MARTINEZPINEIRO JA, 1984, EUR UROL, V10, P93

[44] ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKAEMIA [J]. LANCET, 1969, 1 (7597) : 697 - +

[45] MATTHAY RA, 1982, IMMUNOTHERAPY HUMAN, P69

[46] MCCRACKEN JD, 1982, CANCER, V49, P2252, DOI 10.1002/1097-0142(19820601)49:11<2252::AID-CNCR2820491109>3.0.CO

[47] 2-L

[48] MCCULLOCH PB, 1982, IMMUNOTHERAPY HUMAN, P183

[49] MCKNEALLY MF, 1982, IMMUNOTHERAPY HUMAN, P87

[50] MCPHERSON TA, 1984, 4TH INT C ADJ THER C, P64